Lv3
226 积分 2024-08-23 加入
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors
1个月前
已完结
Erythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy
2个月前
已完结
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target
3个月前
已完结
SHP-1 localization to the activating immune synapse promotes NK cell tolerance in MHC class I deficiency
3个月前
已完结
Natural killer cells’ immune response requires a minimal nanoscale distribution of activating antigens
3个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
4个月前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
5个月前
已完结
Metabolic programs tailor T cell immunity in viral infection, cancer, and aging
7个月前
已完结
皖公网安备34019202002308
